Antimicrobial Agent Abbreviations
Amp- Ampicilin, Amox/Clav- Amoxicillin/Clavulanate, Amp/Sulb-Ampicillin/Sulbactam, Amik- Amikacin, Aztre-Aztreonam, Cefaz- Cefazolin, Ceftaz-Ceftazidime, Cefep-Cefepime, Chloro-Chloramphenicol, Clinda-Clindamycin, Eryth-Erythromycin, Gent-Gentamicin, Imip-Imipenem, Levo-Levofloxacin,Linz-Linezolid, Mero-Meropenem, Nitro-Nitrofurantoin, Norflox- Norfloxacin, Naf-Nafcillin, Pen-Penicillin, Pip/Tazo-Pipercillin/Tazobactam, Quin-Dalf-Quinupristin-Dalfopristin, Tetra-Tetracycline, Tmp/Sxt- Trimethoprim/Sulfamethoxazole, Tobra-Tobramycin, Vanco-Vancomycin
PMC Inpatients, Jan-Dec 2008, Blood Isolates
					Percent Susceptible
Organism	No	Amp or Pen	Cefaz	Clinda	Eryth	Gent	Naf	Tmp/Sxt	Levo	Tetra	Linz	Quin-Dalf	Vanco
S. aureus	71	11	49	59	39	96	49	97	59	NT	100	100	100
Coagulase-negative staphylococci	25	0	16	76	12	76	16	NT	23	NT	96	100	100
Enterococcus sp	20	60	16	NT	5	NT	NT	NT	40	NT	100	35	65
					Percent Susceptible
Organism	No.	Amp	Amp/Sulb or Amox/Clav	Cefaz	Ceftaz	Cefep	Gent	Tobra	Amik	Levo	Pip (Pip/Tazo)	Tmp/Sxt	Mero
E. coli	44	50	64	91	96	98	96	89	98	67	79(98)	76	100
K. pneumoniae	13	0	77	77	77	77	86	77	79	77	0(71)	77	93
P. mirabilis	13	85	92	85	92	92	92	100	100	54	92(100)	77	100
PMC Inpatients, Jan-Dec 2008, Non-Urinary Isolates
					Percent Susceptible
Organism	No	Amp or Pen	Cefaz	Clinda	Ery	Gent	Naf	Tmp/Sxt	Levo	Tetra	Linz	Nitro	Quin-Dalf	Vanco
S. aureus	452	6	47	71	36	98	47	97	66	91	100	99	100	100
Coagulase-negative staphylococci	32	8	44	77	35	85	47	nt	52	NT	100	NT	100	100
Enterococcus sp	74	73	NT	NT	94	NT	NT	NT	56	36	96	59	24	77
Organism	No.	Amp	Amp/Sulb or Amox/Clav	Cefaz	Ceftaz	Cefep	Gent	Tobra	Amik	Levo	Mero	Pip (Pip/Tazo)	Tmp/Sxt
C. freundii	10	0	0	0	70	100	100	100	100	100	100	80	90
E. cloacae	27	0	0	0	93	100	96	100	100	96	100	89(96)	92
E. coli	72	40	52	86	96	96	89	87	98	64	100	66(95)	76
K. pneumoniae	30	0	67	80	80	80	84	80	87	80	87	0(77)	83
K. oxytoca	10	0	100	70	100	100	100	100	100	100	100	0(100)	100
M. morganii	10	0	0	0	100	100	91	100	100	58	100	100(100)	64
P. mirabilis	23	100	100	100	100	100	100	100	100	83	100	100(100)	83
P. aeruginosa	164	NT	NT	NT	89	91	82	90	83	69	85	89	NT
S, marcescens	14	0	0	0	100	100	100	100	100	87	100	100(100)	93
PMC Inpatients, Jan-Dec 2008, Urinary Isolates
					Percent Susceptible
Organism	No	Amp or Pen	Cefaz	Ery	Clinda	Gent	Naf	Nitro	Tmp/Sxt	Levo	Tetra	Linz	Quin-Dalf	Vanco
S. aureus	35	6	49	29	40	97	49	100	100	57	94	100	100	100
Coagulase-negative staphylococci	89	0	29	32	61	78	29	100	NT	32	NT	98	100	100
Enterococcus sp	249	79	NT	16	NT	NT	NT	80	NT	57	26	97	21	81
					Percent Susceptible
Organism	No.	Amp	Amp/Sulb or Amox/Clav	Cefaz	Ceftaz	Cefp	Gent	Tobra	Amik	Levo	Norflox	Nitro	Pip (Pip/Tazo)	Tmp/Sxt	Tetra	Mero
C. koseri	15	0	100	100	100	NT	100	100	NT	100	100	80	NT	100	100	NT
C. freundii	20	0	0	0	95	NT	95	95	NT	100	100	100	NT	95	95	NT
Pantoea (Enterobacter) aerogenes	15	0	0	0	80	NT	100	100	NT	100	100	20	NT	100	93	NT
E. cloacae	24	0	0	0	79	NT	79	75	NT	79	79	25	NT	71	75	NT
E. coli	979	58	83	92	99	NT	93	94	NT	82	82	96	NT	80	79	NT
K. pneumoniae	206	0	83	79	80	NT	90	82	NT	79	79	30	NT	78	83	NT
K. oxytoca	12	0	83	58	100	NT	100	100	NT	92	92	33	NT	83	83	NT
P. mirabilis	93	93	100	97	100	NT	97	99	NT	85	86	0	NT	88	0	NT
P. aeruginosa	51	NT	NT	NT	98	100	86	90	90	63	NT	NT	90	NT	NT	96